Boston Scientific, a leading manufacturer of pacemakers and other cardiac devices, has fallen victim to a cyberattack that has disrupted the remote monitoring capabilities of its newer cardiac implants. This means that data from recently implanted patients is currently unable to be transmitted remotely. The breach was first detected on August 25, 2026, and continues to impact the company’s internal systems. While no further malicious activity has been identified, operations related to manufacturing and shipping have slowed, and some patients with pacemakers are now affected. The company has clarified that the actual function of existing cardiac implants remains unaffected. Remote monitoring systems that were set up before the attack continue to operate normally for patients who had their devices implanted prior to the incident. However, for patients who received newer implants recently, the communication devices used to transmit data to medical professionals are no longer active on the network. This has forced medical teams to conduct in-person visits to manually check the devices, as vital health data is no longer automatically sent to them. Implantable cardiac monitors (ICMs), which are small devices used to detect irregular heart rhythms, are also unable to connect to patients' smartphones. However, these devices continue to record cardiac events on their own. Doctors must now manually retrieve this data during in-person consultations, requiring patients to travel to clinics for necessary checkups. Boston Scientific is working with cybersecurity firm CrowdStrike to address the breach and understand the full extent of the threat. The company hopes to resume some shipments this week, but there is no official timeline for full system recovery or confirmation of the security of personal data stored on its servers. The possibility of a ransomware attack, which could have long-term consequences for Boston Scientific’s operations, remains a significant concern. While the company has not confirmed if ransomware was involved, the disruption highlights the growing vulnerability of medical devices and healthcare infrastructure to cyber threats. Patients and medical professionals are being advised to remain vigilant and follow the guidance provided by the company during this ongoing investigation.